🟢 Amgen is trading 3.08% up in pre-market as investors shift from AI-linked stocks to healthcare

Amgen is trading $465.75, up 3.08%, in pre-market amid a defensive rotation toward healthcare as investors move away from AI-linked stocks.

• Reports offer a sector-level explanation but do not establish a new company-specific catalyst for the October 29 move.
• Amgen is scheduled to report third-quarter 2026 results on November 3, after the U.S. market close—not today.
• No trading-volume or activity-level figures were available in the reviewed sources.